Acta Scientific Clinical Case Reports

Case ReportVolume 3 Issue 6

Guillain Barré Syndrome Associated with Covid-19: A Case Report

Rajendra Prasad S*, Rusheeka Pulluri, Mounika B, Sunil Kumar B, Suchitra Reddy K, P Gandiah and K Sumanth Kumar

Department of General Medicine, SVS Medical College, India

*Corresponding Author: Rajendra Prasad S, Department of General Medicine, SVS Medical College, India.

Received: May 02, 2022; Published: May 23, 2022


The WHO has declared the COVID-19 outbreak a Public Health Emergency of International Concern on 30th January, 2020, and a pandemic on 11th March, 2020. Cases have been reported in 226 countries and territories around the world. More than 517 million people worldwide have been infected so far, with a global mortality rate of approximately 1.2%. The causative agent is a virus designated the SARS-CoV-2. It was initially thought to be solely a respiratory pathogen, however, many observational studies and case reports have documented a high rate of multisystem complications associated with COVID-19. There is growing evidence that SARS‐CoV2 infection could be associated with various neurological complications as well, including but not limited to - headache, dizziness, febrile seizures, encephalitis, encephalopathy, stroke, and acute peripheral nerve diseases. Amongst all the observed neurological manifestations occurring in COVID-19 infected individuals, the commonest ones are ischemic stroke, Guillain-Barré Syndrome (GBS), and hypoxic encephalopathy.

Keywords: COVID-19; SARS‐CoV2; WHO


  1. Maramattom B. “Neurological Complications with COVID-19: A Contemporaneous Review”. Annals of the Indian Academy of Neurology 4 (2020): 468-476.
  2. Sriwastava S., et al. “Guillain Barre Syndrome and its variants as a manifestation of COVID-19: A systematic review of case reports and case series”. Journal of Neurological Sciences 420 (2021): 117263.
  3. Scheidl E., et al. “Guillain-Barré syndrome during SARSCoV-2 pandemic: A case report and review of recent literature”. Journal of the Peripheral Nervous System 2 (2020): 204-207.
  4. Khan F., et al. “COVID-19-associated Guillain-Barre syndrome: Postinfectious alone or neuroinvasive too?” Journal of Medical Virology10 (2021): 6045-6049.
  5. Rahimi K. “Guillain-Barre syndrome during COVID-19 pandemic: an overview of the reports”. Neurological Sciences 41 (2020): 3149-3156.
  6. Adams and Victor's Principles of Neurology, 11e Eds. Allan H. Ropper., et al. McGraw Hill, (2019): 1322.

Citation: Rajendra Prasad S., et al. “Guillain Barré Syndrome Associated with Covid-19: A Case Report". Acta Scientific Clinical Case Reports 3.6 (2022): 57-59.

Copyright: © 2022 Rajendra Prasad S., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is June 25, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US